NASDAQ: CRVS
Corvus Pharmaceuticals Inc Stock Ownership - Who owns Corvus Pharmaceuticals?

Insider buying vs selling

Have Corvus Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
William Benton JonesSVP Pharmaceutical Development2025-06-0419,357$3.50
$67.75kBuy
Richard A. Md MillerPresident and CEO2025-05-07559,073$3.50
$1.96MBuy

1 of 1

CRVS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRVS insiders and whales buy or sell their stock.

CRVS Shareholders

What type of owners hold Corvus Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Orbimed Advisors LLC9.00%6,943,654$29.09MInsider
Peter A. Thompson9.00%6,943,654$29.09MInsider
Orbimed Advisors LLC9.00%6,943,654$29.09MInstitution
Ecor1 Capital LLC6.69%5,162,154$21.63MInsider
Samlyn Capital LLC5.27%4,065,935$17.04MInstitution
Terry P. Gould4.41%3,402,422$14.26MInsider
Adams Street Partners LLC4.41%3,402,422$14.26MInsider
Adams Street Partners LLC4.25%3,275,616$13.72MInstitution
Point72 Asset Management LP3.61%2,787,631$11.68MInstitution
Rtw Investments LP3.47%2,679,479$11.23MInstitution

1 of 3

CRVS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRVS47.03%39.69%Net BuyingNet Buying
ATXS80.89%19.11%
AURA79.28%18.77%Net SellingNet Buying
OCGN26.27%10.45%Net Selling
RCKT59.15%40.85%Net SellingNet Buying

Corvus Pharmaceuticals Stock Ownership FAQ

Who owns Corvus Pharmaceuticals?

Corvus Pharmaceuticals (NASDAQ: CRVS) is owned by 47.03% institutional shareholders, 39.69% Corvus Pharmaceuticals insiders, and 13.27% retail investors. Orbimed Advisors LLC is the largest individual Corvus Pharmaceuticals shareholder, owning 6.94M shares representing 9.00% of the company. Orbimed Advisors LLC's Corvus Pharmaceuticals shares are currently valued at $29.09M.

If you're new to stock investing, here's how to buy Corvus Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.